The end of the official shortage status for semaglutide came as telehealth company Hims & Hers – which has been pushing sales ...
Semaglutide — the key ingredient in Ozempic and Wegovy — had been in shortage since 2022. Now that supply has stabilized, state-licensed compounding pharmacies and physicians must stop selling ...
On Friday, the Food and Drug Administration declared the semaglutide shortage over, sending Hims & Hers shares down 26%.
In a letter to employees released Monday, CEO Brian Niccol said the company will inform employees who are being laid off by ...
Phase 1b Study receives lead clinical site approval KELOWNA, BC / ACCESS Newswire / February 24, 2025 / Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW) (the "Company" or "Lexaria"), a global ...
It’s hard to watch television without seeing advertisements for compounded GLP-1 weight-loss drugs cheaper than the authentic ...
In a deft piece of cultural observation during the highly entertaining Apple TV comedy, Shrinking, one of the characters Liz, ...